BACKGROUND: Polymorphous adenocarcinoma (PAC) of the palatal minor salivary glands, previously known as polymorphous low-grade adenocarcinoma, is the second most common intraoral malignant salivary gland carcinoma after adenoid cystic carcinoma (ACC) and carries an excellent prognosis. Unfortunately, PAC demonstrates cytological overlap with 2 other salivary gland tumors frequently encountered in the same location, namely ACC and pleomorphic adenoma (PA). Recently, the protein kinase D1 (PRKD1) hotspot mutation E710D was demonstrated to be specific for PAC and to be present in the majority of cases. The objective of the current study was to investigate the value of PRKD1 hotspot sequencing in identifying PAC in paired fine-needle aspiration (FNA) and surgical specimens from cases of PAC, ACC, and PA. METHODS: Paired May-Grunwald-Giemsa-stained FNA and corresponding surgical specimens were collected from 18 PAC cases, 25 ACC cases, and 21 PA cases. Both sets of specimens were subjected to dideoxynucleotide sequencing of PRKD1 exon 15, including the PRKD1 E710D hotspot. RESULTS:
INTRODUCTION
The appropriate clinical management of patients presenting with a palatal mass relies heavily on the cytopathologist for an accurate preoperative diagnosis. Although the most frequent malignancy at this site is squamous cell carcinoma, tumors arising from the minor salivary glands constitute the second largest group. This latter group is immensely diverse, but 3 entities collectively constitute the vast majority of these tumors, namely the subset of polymorphous adenocarcinoma (PAC), previously known as polymorphous low-grade adenocarcinoma (PLGA); adenoid cystic carcinoma (ACC); and pleomorphic adenoma (PA) . 1 These tumors demonstrate a significant cytological overlap and are all matrix-containing tumors. The cytomorphology of PAC is virtually indistinguishable from that of ACC and PA, and its background can mimic the fibrillary matrix of PA and the hyaline globules of ACC. Nevertheless, the distinction between these entities is of paramount importance because their aggressiveness, and thus the extent of surgical resection required, is markedly different. 2 This holds especially true for ACC because clear surgical margins can be unattainable due to extensive perineural invasion and maxillary reconstruction can be necessary in the case of bone invasion. Fine-needle aspiration (FNA) specimens are excellent sources for molecular diagnostics because tumor cells are directly smeared without the use of DNAdamaging fixatives. 3 Numerous types of salivary gland tumors are characterized by pathognomonic chromosomal rearrangements, including MYB proto-oncogene (MYB) rearrangements in ACC and pleomorphic adenoma gene 1 (PLAG1) rearrangements in PA, and fluorescence in situ hybridization (FISH) has been shown to be useful in identifying these rearrangements also on FNA (eg, mastermind-like transcriptional coactivator 2 [MAML2] in mucoepidermoid carcinoma and ETS variant 6 [ETV6] in secretory carcinoma). 4 However, up to 50% of cases of ACC and PA have been shown to have intact MYB and PLAG1 genes, respectively, making the specificity of gene rearrangement very high whereas the sensitivity is only modest. 4, 5 Recently, recurrent point mutations in nucleotide 2130 in exon 15 of the protein kinase D1 (PRKD1) gene were shown to be specific for PAC and to be present in nearly 75% of cases. 6 These mutations lead to an amino acid change from glutamic acid to aspartic acid in codon 710 (E710D), leading to increased catalytic activity of the kinase domain, and can be expected to serve as a specific molecular marker and potential therapeutic target. 6 By examining the prevalence of the PRKD1 hotspot mutation in a series of paired FNA and surgical specimens of PAC, ACC, and PA, the objective of the current study was to investigate the feasibility of this novel molecular marker in distinguishing these entities. This could prove to be a valuable expansion of the molecular armamentarium applicable to head and neck FNA and could improve preoperative diagnostics for these 3 cytological look-alike palatal tumors originating in the minor salivary glands.
MATERIALS AND METHODS

Patient Material
The surgical pathology archives at the study institutions were searched for all intraoral or soft palate specimens that carried a diagnosis of PLGA or PAC from 2000 to 2014. Additional patients were included prospectively from 2015 through 2017. Cribriform variants of PAC (equivalent to cribriform adenocarcinoma of the tongue) were excluded because their genetics are different and are characterized by structural genetic rearrangements involving the PRKD1, PRKD2, and PRKD3 genes. 7, 8 This identified a total of 16 PAC surgical specimens from different patients, all of which had available FNA specimens (stained with MayGrunwald-Giemsa staining). FNA specimens from 2 histologically verified PACs were included despite the surgical specimens being unavailable. An otolaryngologist performed all FNAs and 1 to 3 slides were available from each patient. The original FNA diagnoses from PAC FNA specimens were "tumor cells" or "benign salivary gland tumor or low-grade malignancy." Surgical specimens and corresponding FNA specimens from 25 ACC cases and 21 PA cases also were retrieved. Hematoxylin and eosinstained surgical slides were reviewed by 2 head and neck pathologists (T.K.A. and K.K.) according to the 2017 World Health Organization classification to ensure the correct diagnosis. 7 All FNA specimens were reviewed to ensure the presence of tumor cells (>20% of cells on the FNA specimen) for DNA sequencing. Clinical and demographic information was collected from the patient files. The eighth edition of the American Joint Committee on Cancer staging manual was used for disease staging. 9 The current study was approved by the Regional Ethics Committee (H-6-2014-086) and the Data Protection Agency (REG-94-2014).
Dideoxynucleotide Sequencing of PRKD1 Exon 15
Genomic DNA was extracted from sections measuring 4 lm 3 10 lm from formalin-fixed and paraffin-embedded tissue blocks from the surgical specimens using the QIAamp DNA mini kit (Qiagen, Hilden, Germany) on a QIAcube (Qiagen) instrument according to the manufacturer's instructions. Genomic DNA was extracted from and T7 sequences, respectively]), 25 lL of RedEx PCR master mix (Sigma-Aldrich), and 1 lL of 100-fold diluted nest 1 product. The PCR conditions were the same as for the nest 1 reactions except that 35 cycles were used. PCR products were isolated using the QIAquick PCR Purification Kit (Qiagen). For sequencing using the T3 and T7 primers, 25 ng of purified PCR products were used for BigDye incorporation using the BigDye Terminator v3.1 Cycle Sequencing Kit (Thermo Fisher Scientific) and sequenced on an Applied Biosystems ABI 3500 Dx Genetic Analyzer in accordance with the manufacturer's instructions (Thermo Fisher Scientific). A nontemplate control (water) was run in parallel for all reactions. Electropherograms were interpreted blinded to diagnosis by 2 of us (M.G. and L.C.M.). The specificity of the PRKD1 hotspot mutations was calculated as the true-negative findings/(true-negative 1 false-positive findings) and the sensitivity was calculated as the true positive findings/(true-positive 1 false-negative findings). 
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RESULTS
Demographic Data
Demographics for patients with PAC are summarized in Table 1 . 9 The male-to-female ratio was 1:1.6 and the median age of the patients was 60 years (range, 37-80 years). The palate was the most frequent site for PAC (6 cases in the hard palate and 9 cases in the soft palate), with the upper lip, buccal mucosa, and retromolar trigone being the PAC site in 1 case each (Table 1) 9 (Fig. 1A) . All patients were classified as having American Joint Committee on Cancer stage I (7 patients; 38.9%) or stage II (11 patients; 61.1%) disease at the time of diagnosis and were without regional or distant involvement.
Histology and Cytomorphology
Histologically, PAC cases demonstrated characteristically varied growth patterns but very uniform cytological features (Fig. 1B) . Growth patterns included areas of solid, cribriform, trabecular, fascicular, and papillary configurations in varied proportions along with the characteristic targetoid pattern of perineural invasion. The tumor stroma was composed of fibrous tissue demonstrating varying degrees of hyalinization and myxoid change, although not to a degree resembling the chondromyxoid matrix in PA. Overall, the cytological appearance of all 3 tumor types was very similar, with specimens being cellular and consisting of branching pseudopapillae, and sheets and clusters of uniform tumor cells with dispersed chromatin and inconspicuous nuclei (Figs. 2A-2D and Figs. 3A-3C ). Mitoses and necrosis were not observed. Characteristically, abundant hyaline globules were present in glandular formations in all cases of PAC, highly resembling those of ACC (Figs. 2B and 2C and Fig. 3A) . In the majority of cases, the background had areas of myxohyaline material resembling that of PA (Fig. 2D and Fig. 3C ). 
PRKD1 E710D Hotspot Mutation Analysis
Nine of 18 PAC cases (50%) were found to harbor the PRKD1 E710D hotspot mutation (c.2130A>T in 4 cases and c.2130A>C in 5 cases), and the remaining 9 cases (50%) were normal (Fig. 4) ( Table 2 ). Seven of these cases had available surgical specimens, all of which had identical mutations as the FNA specimen. One ACC case had a PRKD1 p.A693P (c.2077G>C) mutation and another had a p.L707F (c.2119C>T) mutation. No abnormalities in PRKD1 were found in any of the PA cases. As such, the specificity of the c.2130 substitution was 100% and the sensitivity was 50% (95% confidence intervals of 92.3%-100% and 26%-74%, respectively) in separating PAC from ACC and PA on FNA.
DISCUSSION
PAC (previously termed PLGA) is an uncommon malignancy of the salivary glands mainly affecting the intraoral minor salivary glands, with only rare cases reported in the major salivary glands. 10 Despite the "low-grade" part of its name being removed in the current World Health Organization classification, the favorable prognosis of PAC makes it essential to separate this entity from ACC, which is locally invasive with frequent disease recurrences and a propensity toward late distant spread. 7, 11, 12 Therefore, an accurate preoperative diagnosis is important for surgical planning and when informing patients. Separating PAC from ACC and PA has been a dilemma for cytopathologists and histopathologists alike for decades. 13, 14 In contrast to ACC and PA, PAC is a monophasic tumor and a recent study demonstrated a consistent p63-positive/p40-negative immunophenotype to be reserved for PAC. 14 Although this aids in diagnosing macroscopic specimens as well as small incisional biopsies, this finding is not readily transferrable to the cytological setting, especially in cases in which few slides are available or only a few tumor cells are present on each slide. In the same way, due to the limited amount of material, immunocytochemical panels are not easily applied. 15 Chromosomal rearrangements define the majority of salivary gland tumors, including the subset of PAC previously known as cribriform adenocarcinoma of the tongue. 8, 16 However, to the best of our knowledge, the "classic" variant of PAC investigated herein (ie, the subset of PAC previously known as PLGA) is among the few salivary gland entities characterized by recurrent and highly specific point mutations. 6, 17, 18 Point mutations are welldescribed in patients with ACC, but, except for a predilection for NOTCH1, these mutations are diverse and are likely to arise in the background of the otherwise fusiondriven ACC in the majority of cases. 19 The Despite these limitations of FISH, to the best of our knowledge this is the only feasible method with which to demonstrate genetic rearrangements for routine purposes because fusion partner genes and chromosomal breakpoints in ACC as well as PA are too diverse to be routinely investigated with conventional reverse transcriptase-PCR. In the cases reported in the current study, all PAC cases demonstrated the same mutation on the FNA specimen as well as the surgical specimen without difficulties in interpretation. However, 2 ACC cases had mutations in the PRKD1 gene close to the nucleotide encoding the E710D hotspot, thereby emphasizing the necessity to adhere to only the hotspot mutations when interpreting these data.
The results of the current study demonstrate that detection of the PRKD1 E710D hotspot mutation using FNA is a feasible and highly specific method with which to identify PAC cases among its main cytological mimics. However, because the sensitivity of this method is only modest, cases without hotspot mutations should be interpreted with caution.
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